The Organon Access Program

Organon offers The Organon Access Program to assist patients who have been prescribed Ontruzant (Table).

The Organon Access Program

The Organon Access Program can assist with benefit investigation, prior authorizations, the appeal process, and offers the Organon Co-pay Assistance Program as well as the Organon Patient Assistance Program.

The Organon Co-pay Assistance Program

Once enrolled, eligible, privately insured patients pay the first $5 of their copay per infusion. The maximum copay assistance program benefit is $25,000 per patient, per calendar year. Patients may be eligible for copay assistance if they:

• Are a resident of the United States
• Have private health insurance that provides coverage for Ontruzant under a medical benefit program
• Have been prescribed Ontruzant for an FDA-approved indication
• Are not covered under a government program as that term is defined in the Terms and Conditions
• Meet all other terms and conditions of the program.

The Organon Patient Assistance Program

The Organon Patient Assistance Program is primarily designed to help those who do not have insurance coverage; however, if your patient has insurance coverage for Ontruzant, including Medicare Part D, but still has trouble paying for their medicine, they may request that an exception be made, provided their income is not above a set limit and they meet certain other medical and/or insurance criteria. Patients may be eligible if they:

• Are a US resident and have a prescription for Ontruzant from a healthcare provider licensed in the United States
• Do not have insurance or other coverage for a prescription medicine
• Cannot afford to pay for their medicine and have a household income of $64,400 or less for individuals, $87,100 or less for couples, or $132,500 or less for a family of 4.

Click here for more information on The Organon Patient Assistance Program, or call 888-727-0015.

TABLE Organon Oncology Drug